DaShenLin Pharmaceutical Group Co., Ltd.

Shanghai Stock Exchange 603233.SS

DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -80.21 M

DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid is USD -80.21 M for the year ending December 31, 2023, a -39.96% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -57.31 M, a 30.89% change year over year.
DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -82.92 M, a -64.94% change year over year.
DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -50.28 M, a -45.88% change year over year.
DaShenLin Pharmaceutical Group Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -34.46 M, a 9.78% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

CEO	Mr. Guoqiang Ke
IPO Date	July 31, 2017
Location	China
Headquarters	410 Longxi Avenue
Employees	45,466
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.

Key trends

Past 5 years